EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Long-term hydroxyurea therapy alters bone marrow megakaryocyte morphology and associates with prognosis in myeloproliferative neoplasms

Zhikang Zheng, Yingqing Xu, Tian Zeng, Rumeng Li, Bingbing Wen, Qingmei Han, Xiaojing Bao, Jian Huang

Annals of Hematology · 24.07.2026 · 105 (11)

DOI: 10.1007/s00277-026-07202-x ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Annals of Hematology, online erschienen am 24.07.2026. Verfasst von Zhikang Zheng und 7 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Bone Marrow, Hydroxyurea, Megakaryocytes, Myeloproliferative Disorders. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hydroxyurea (HU) is a first-line treatment for myeloproliferative neoplasms (MPNs), but a quantitative, standardized framework for assessing its impact on megakaryocyte (MK) morphology and prognosis remains lacking. This retrospective, two-center study analyzed 22,097 MKs from 280 patients (118 polycythemia vera [PV], 162 essential thrombocythemia [ET]), classified into 12 subtypes using the 5th edition WHO classification in conjunction with objectively derived thresholds (minimum P-value approach). Our primary contribution is to establish a quantifiable scoring framework that translates descriptive WHO categories into reproducible prognostic metrics. Using this framework, HU significantly reduced normal MK proportion in JAK2-ET ( P = 0.0189), TN-ET ( P = 0.0233), and JAK2-PV ( P = 0.0427), while increasing abnormal subtypes (bulbous, separated nuclear MKs); conversely, IFN was associated with preserved normal MKs and reduced abnormal forms. Multivariate Cox regression, applied to our empirically derived cutoffs, identified protective thresholds (normal MK ≥ 58% in ET, ≥ 53% in PV; emperipolesis ≥ 2% in ET) and adverse cutoffs (Naked nuclei ≥ 13% in ET, ≥ 7% in PV; staghorn like ≥ 6% in ET; separated nuclear ≥ 3% in ET) for myelofibrosis progression (all P < 0.05). Our quantitative findings corroborate prior qualitative observations that long-term HU is associated with adverse MK remodeling, while IFN correlates with lower progression risk as captured by our threshold-based system. This standardized scoring approach—not the identification of new prognostic factors—provides a reproducible tool for monitoring treatment-related morphological changes and may inform risk-adapted therapy in MPN patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone MarrowHydroxyureaMegakaryocytesMyeloproliferative DisordersAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedPolycythemia VeraPrognosisRetrospective StudiesThrombocythemia, Essential

Stichwörter der Autor:innen

HydroxyureaInterferonMegakaryocyte morphologyMyeloproliferative neoplasmsPrognosis

Substanzen

Hydroxyurea

Autor:innen und Institutionen

  • The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • The Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu, China.
  • The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China. househuang@zju.edu.cn.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zheng, Z., Xu, Y., Zeng, T., Li, R., Wen, B., Han, Q., Bao, X., & Huang, J. (2026). Long-term hydroxyurea therapy alters bone marrow megakaryocyte morphology and associates with prognosis in myeloproliferative neoplasms. Annals of Hematology, 105(11). https://doi.org/10.1007/s00277-026-07202-x

Vancouver

Zheng Z, Xu Y, Zeng T, Li R, Wen B, Han Q, et al. Long-term hydroxyurea therapy alters bone marrow megakaryocyte morphology and associates with prognosis in myeloproliferative neoplasms. Annals of Hematology. 2026;105(11). doi:10.1007/s00277-026-07202-x

BibTeX
@article{Zheng2026,
  author = {Zheng, Zhikang and Xu, Yingqing and Zeng, Tian and Li, Rumeng and Wen, Bingbing and Han, Qingmei and Bao, Xiaojing and Huang, Jian},
  title = {Long-term hydroxyurea therapy alters bone marrow megakaryocyte morphology and associates with prognosis in myeloproliferative neoplasms},
  journal = {Annals of Hematology},
  year = {2026},
  volume = {105},
  number = {11},
  doi = {10.1007/s00277-026-07202-x}
}
Kostenlos starten →